Back to Top

Information For Authors

Submit Your Manuscript

Statement of Purpose and Policy

Journal of Palliative Medicine will accept original manuscripts that contain material that has not been reported elsewhere, except in the form of an abstract. Prior abstract presentations should be described in a footnote to the title. Submissions should be accompanied by a letter requesting evaluation for publication.

Mary Ann Liebert, Inc. Submission Benefits Package

Your submission to Journal of Palliative Medicine provides you with robust tools and support to ensure maximum impact and readership for your work. By submitting your manuscript, you’ll receive:

  • Rapid, rigorous peer-review and editorial attention
  • Immediate deposit to PubMed and other indexing services upon online publication
  • Exposure to thousands of thought-leaders in your field, maximizing readers, citations, and downloads
  • Fast Track online-ahead-of-print publication
  • Global availability in over 170 countries
  • Open Access publication options


Submitting your manuscript to Journal of Palliative Medicine delivers a comprehensive benefits program that ensures high-quality review of your research and maximum impact for your work. Journal of Palliative Medicine carries a manuscript processing charge* of $49 USD upon submission of each new manuscript.

Upon payment, you will be provided a Manuscript Submission Code, and will be prompted to enter this information when uploading your files to our peer-review system.  Please note:  Securing a token does not automatically create an account in our peer-review system. If you do not already have an account, you will be asked to create one before you can begin your submission.

Submissions do not need to be completed at once. Submitting authors/agents may begin the submission process, save their work, and return to the site to complete the upload(s) at a later time. There is no limit on the number of times one can save their work and subsequently resume the submission. Doing so will not incur additional charges.

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

Click here to submit your paper via our fast and user-friendly electronic submission system.


Processing charges and submission codes are NOT required for revisions to previously submitted papers. To upload a revision of a paper, the submitting author should log in to their Author Center at click on “Revised Manuscripts in Draft.” The paper will appear in this area, and the submitting author will be able to upload revised files without paying any charges or entering a submission code.

Please be sure to follow the Instructions for Authors below on Manuscript Preparation.  Authors whose submissions do not comply with the Instructions for Authors will have their papers un-submitted so that the file(s) may be adjusted accordingly. Directions regarding the necessary corrective actions will be provided in an email to the corresponding author at the time the paper is un-submitted. The submitting author/agent will then be provided the opportunity to re-upload the corrected file(s). If a paper is un-submitted, the paper will reside in the corresponding author’s “Author Center” as a draft, and the submitting author/agent will be able to make the necessary adjustments and re-upload the paper without incurring another manuscript processing charge. 

*The manuscript processing charge is independent of editorial decision and is non-refundable.


Please read all the instructions to authors before submitting.

Follow all prompts on Manuscript Central for inputting all required manuscript details. Please upload all files pertaining to your paper individually; do NOT combine all manuscript files into one PDF for uploading. Manuscript Central prepares a PDF proof after uploading is completed.

Preparation of Original Manuscript


Original manuscripts may NOT exceed 3,000 words, excluding references, tables, figures and appendixes. Original manuscripts are generally reports of completed research studies. There are ample sample sizes, statistical analyses, and firm conclusions from the work can be drawn. Submissions over 3,000 words will be returned to the author. Leave ample margins on both sides, top, and bottom of manuscript text file. A structured abstract of 250 words or less, using the following guidelines, must be included and should be self-explanatory without reference to the text:

  • Background (Why was this report needed)
  • Objective (What did you set out to do?)

  • Design (How did you go about doing it)

  • Setting/Subjects (If this was a clinical trial, in what setting was it done and who were the subjects)

  • Measurements

  • Results (What did you discover)

  • Conclusions

Number pages consecutively, including the title page.  A title page with information for all authors including full names, degrees, affiliations and contact information should be included and uploaded separately. The main document should be a blind submission with no author names or affiliations. The manuscript file should also contain the abstract after the title page, and before the introduction.


Preparation of Brief Report


In contrast with Original Manuscripts, brief reports may not exceed 1500 words. This category is for research that is less well-developed than reported in an original manuscript. The results of preliminary studies, pilot programs, or small series on which an hypothesis can be formulated and tested in a subsequent study are good candidates for this category. The Journal of Palliative Medicine is particularly interested in fostering the careers of junior investigators, or those new to the field of palliative medicine research. This category fills a need for those reports worthy of dissemination, but not worthy of 3,000 words to tell the story. Please include a structured abstract as for an original manuscript.

Preparation of a Letter

Results of research or the development of ideas that do not fit the criteria for a brief report may be reported in a letter. Not more than 500 words, letters are often the richest source of new insights or serendipitous observations on which the future of the field may turn. This section is meant to transmit information that is much more ‘raw’ or ‘untested’, but holds promise in furthering the field through stimulating further research, discussion, or resolving controversy. A small number of references, no more than 4, may accompany a letter.  Only one table or one figure and no more than a total of 4 references are permitted for the Letters.

Preparation of an Editorial or Special Report

From time to time, an unsolicited report from an important group or meeting, or a description of a phenomenon in the field, or a particular point of view deserves publication. These decisions rest solely with the editor-in-chief.

Preparation of a Personal Reflection

One of the most widely read features in the journal, the personal reflections are written in a way that illustrates the personal engagement with the field—either its struggles or its joys or the complex combination of the two. Prose and poetry have all found a place here. Acceptance is at the sole discretion of the Managing Editor and Editor.


Preparation of Case Discussions

Types of cases:

Case Discussions in Palliative Medicine presents case-based examinations of topics relevant to the practice of palliative care. The Journal welcomes manuscripts that fit the traditional case report paradigm, e.g. a description of a rare diagnosis, unusual outcome, or new treatment modality. Reports of meaningful cases that do not necessarily report something “unusual,” but that would be of interest to a broad palliative care audience are also encouraged. We strongly encourage use of the existing evidence base. The main ‘outcome’ against which we will measure submissions is:

  • will a community physician or nurse practitioner be able to look at this, and
  • feel s/he has attended a worthwhile discussion, and
  • come away with one thing s/he might do differently in his/her practice?

In addition to traditional medical cases, The Journal welcomes cases illustrating issues that go beyond medical knowledge and patient care.   Using the six ACGME competencies* as an inspiration, we encourage submission of case discussions that address communication issues, ethics, professionalism, and systems-based practice.


Length: 2000 words or less (excluding abstract, references, acknowledgments, disclosures tables, figures)


Format:   Abstract;  Introduction;  Case Description;  Discussion;   References


A successful manuscript will meet the following criteria:


  • Material is original and has not been published elsewhere. (Cases previously presented as posters or abstracts may be accepted.)
  • Writing is clear and in accordance with the AMA Manual of Style, 10th edition.

All words should be spelled in American English


*Six ACGME competencies:    Medical Knowledge;    Patient Care;  Interpersonal and Communication; Skills;    Professionalism;  Practice-based Learning and Improvement;   Systems-based Practice


For definitions of the ACGME competencies, please refer to:



Unless otherwise noted, Journal of Palliative Medicine follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. See: Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med. 1997;126:36–47.

Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” This text must be part of your actual manuscript file.

In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.


Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at for further guidance.


If no conflicts exist, the authors must state “No competing financial interests exist.”

File Naming

  • Name all files in English and use only alphanumeric characters.  Do not use symbols, dots, lines, or dashes.
  • Figure files names should be formatted with first author’s last name and the figure number. (Ex:  SmithFig1)


  • Prepare each figure as individual .TIFF or .EPS file. 
  • Do NOT submit figures in Word, PowerPoint, PDF, Bitmap, .JPEG, or Excel.
  • Line illustrations must be submitted at 900 DPI.
  • Halftones and color should be submitted at a minimum of 300 dpi.
  • Color art must be saved as CMYK - not RGB. (N.B., If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
  • Black and white art must be submitted as grayscale – not RGB.

Additional Information on Converting Figure Files

Converting Word or Excel files: The best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

  • All files should be scanned at 100% size
  • At least 300 dpi
  • Final color mode: CMYK
  • Save file as: .tif, .tiff, or .eps

For more direction on how to convert a Power Point slide to acceptable format go to:


  • Prepare and save each table in individual .doc or .docx files.
  • Do not include tables in the main manuscript text file.
  • Do not embed tables within the text.
  • Include a table number and a title for each supplied table. 
  • Use Arabic numerals to number tables.
  • Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
  • Define all acronyms used within the body of the table in table footnotes.
  • All other types of table footnotes should be designated using superscript letters, not symbols.
  • Name all table files in English and use only alphanumeric characters.  Do not use symbols, dots, lines, or dashes.
  • Table file names should be formatted with first author’s last name and the table number. (Ex:  SmithTable1)
  • Upload individual table file under the “Table” file designation.


Please upload individual files of all manuscript material - do NOT upload a single PDF file containing all text, figure, and table files of your article.  Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.



Abbreviations of journal titles should follow MEDLINE.



References should be presented in numerical order and in the following style:


  • Journal articles: Christakis NA, Escarce JJ: Survival of medicare patients after enrollment in hospice programs. New Engl J Med 1996;335:172–178.
  • Chapter in a book: Lipman AG, Gauthier ME: Pharmacology of opioid analgesics: Basic problems.
    In: Portenoy RK, Bruera E (eds): Topics in Palliative Care, Volume I.  New York: Oxford University Press, 1997, pp. 137–162.
  • Book: Oxford Textbook of Palliative Medicine, 3e. Doyle D, Hank G, Cherny N (eds). Oxford University Press, New York, NY, 2005.

For references containing more than four authors, list the first three, followed by et al.


If it is necessary to cite an abstract, this should be designated.


Authors are responsible for the accuracy of the reference, and are reminded that inaccurate references are highly frustrating to the reader, the cited author, and indexing services.



The author(s) must obtain permission to reproduce figures, tables and text from previously published material. Written permission  must  be  obtained  from  the  original  copyright  holder (generally the publisher, not the author or editor) of the journal or  book  concerned. An appropriate credit line should be included in the figure or legend or table footnote, as well as in the reference list. Written permission must be obtained from the author of any unpublished material cited from other sources, and should accompany the manuscript.


Reprints may be ordered by using the special reprint order form that will accompany page proofs. Reprints ordered after the issue is printed will be charged at a substantially higher rate.


The Journal is published twelve times a year by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: 914-740-2100; fax: 914-740-2101; email:

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Explore Liebert Open Access

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

  • High visibility; open access articles are freely available online upon publication
  • You retain copyright with the open access license allowing broad dissemination of your research
  • You can freely share your article in repositories and research networks without restrictions
  • Easy compliance with open access mandates
  • Rigorous editorial and peer-review
  • Targeted email announcement featuring a direct link to article

Identification and Marketing

Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing

If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access

Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?

Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.